Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00330447 · ClinicalTrials.gov registry record
Effects of Oncological Treatment During Pregnancy on Mother and Child
A clinical trial of Cancer and Pregnancy, sponsored by University Hospital, Gasthuisberg.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 20
- Study locations
NCT00330447 is a study of Cancer and Pregnancy that is actively recruiting participants, run by University Hospital, Gasthuisberg. The registered enrollment target is 5,000 participants, above the 3,483-participant average among 615 other Cancer trials with a reported enrollment target (44% higher). The trial reports 20 study locations across 2 states.
The verdict
NCT00330447, a study of Cancer and Pregnancy, is actively recruiting participants, sponsored by University Hospital, Gasthuisberg.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The researchers aim to investigate the outcome (overall survival) of mothers who are diagnosed and/or treated for cancer during pregnancy. Furthermore they want to test the hypothesis that children who were exposed to cancer or cancer treatment (cytotoxic drugs, radiation therapy, targeted therapy,...) develop normally (neurologic and cardiologic examination).
Study Locations (20)
Other
- Instituto Alexander Fleming - Buenos Aires
- Universitätsklinik für Frauenheilkunde und Geburtshilfe (retrospective 2016-2018) - Graz
- UCL Brussels (2013-ongoing) - Brussels
- UZ Gasthuisberg, Katholieke Universiteit Leuven (2004-ongoing) - Leuven
- University Hospital Ostrava (2018-ongoing) - Ostrava
- 3rd medical faculty of Charles University (2010-ongoing) - Prague
- Copenhagen University Hospital (2015-ongoing) - Copenhagen
- Hopital Bichat-Claude-Bernard (retrospective until 2018) - Paris
- Universitätsklinik Freiburg (retrospective until 2018) - Freiburg im Breisgau
- Euroclinic Hospital (2016-ongoing) - Athens
- Hellenic Anticancer-Oncological Hospital of Athens (retrospective 2015-2018) - Athens
- Ioannina University Hospital (retrosepctive 2015-2018) - Ioannina
- Hippokration Hospital (retrospective 2015-2018) - Thessaloniki
- European Institute of Oncology (2010-ongoing) - Milan
- Fondazione IRCCS Ca'Granda Ospedale Maggiore (2012-ongoing) - Milan
- Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico Milano (2017-ongoing) - Milan
- San Raffaele Hospital (2017-ongoing) - Milan
- CIttà della Salute e della Scienza di Torino (2015-ongoing) - Torino
- Regional Hospital of High Specialty of Ixtapaluca (2018-ongoing) - Ixtapaluca
New Jersey
- Cooper University Hospital (2015-ongoing) - Camden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2005-08 |
| Est. Completion | 2032-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00330447
The ClinicalTrials.gov registry entry for NCT00330447 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,483-participant average among 615 other Cancer trials with a reported enrollment target (44% higher). The listed sponsor is University Hospital, Gasthuisberg, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00330447 reports 20 study locations spanning 2 distinct geographic areas - top geographies include Other, New Jersey.
Frequently Asked Questions
What is clinical trial NCT00330447 about?
NCT00330447 is a clinical study titled "Effects of Oncological Treatment During Pregnancy on Mother and Child". The researchers aim to investigate the outcome (overall survival) of mothers who are diagnosed and/or treated for cancer during pregnancy. Furthermore they want to test the hypothesis that children who were exposed to cancer or cancer treatment (cytotoxic drugs, radiation therapy, targeted therapy,....
What is the current status of trial NCT00330447?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2005-08. Estimated completion is 2032-12.
What conditions does trial NCT00330447 study?
This clinical trial studies the following conditions: Cancer, Pregnancy.
Who is sponsoring clinical trial NCT00330447?
This trial is sponsored by University Hospital, Gasthuisberg, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00330447 being conducted?
This trial has 20 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.